Effect of culture medium on the disk diffusion method for determining antifungal susceptibilities of dermatophytes

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 6, 2006, Pages 2222-2224

  Fernández Torres, Belkys ^a   Carrillo Muñoz, Alfonso ^b   Inza, Isabel ^a   Guarro, Josep ^a,c  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^b Asesoria Cientifica y de Investigacion Aplicada   (Spain)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; RAVUCONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DERMATOPHYTE; DIFFUSION; DISK DIFFUSION; FUNGAL STRAIN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECIES;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CULTURE MEDIA; DIFFUSION; EVALUATION STUDIES; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY;

EID: 33744466791     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01443-05     Document Type: Article

References (21)

1. Arikan, S., M. Lozano-Chiu, V. Paetznick, S. Nangia, and J. H. Rex. 1999. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J. Clin. Microbiol. 37:3946-3951.
2. Arikan, S., V. Paetznick, and J. H. Rex. 2002. Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates. Antimicrob. Agents Chemother. 46:3084-3087.
3. Esteban, A., M. L. Abarca, and F. J. Cabañes. 2005. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes. Med. Mycol. 43:61-66.
4. Fernández-Torres, B., A. Carrillo-Muñoz, M. Ortoneda, I. Pujol, F. J. Pastor, and J. Guarro. 2003. Interlaboratory evaluation of the Etest for antifungal susceptibility testing of dermatophytes. Med. Mycol. 41:125-130.
5. Fernández-Torres, B., F. J. Cabañes, A. J. Carrillo-Muñoz, A. Esteban, I. Inza, L. Abarca, and J. Guarro. 2002. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J. Clin. Microbiol. 40:3999-4003.
6. Fernández-Torres, B., I. Inza, and J. Guarro. 2005. Evaluation of disk diffusion method for determining eberconazole susceptibility of dermatophytes and influence of culture medium. Antimicrob. Agents Chemother. 49:2116-2118.
7. Kane, J., R. Summerbell, L. Sigler, S. Krajden, and G. Land. 1997. Laboratory handbook of dermatophytes: a clinical guide and laboratory handbook of dermatophytes and other filamentous fungi from skin, hair, and nails. Star Publishing Co., Belmont, Calif.
8. Liebowitz, L. D., H. R. Ashbee, E. G. V. Evans, Y. Chong, N. Mallatova, M. Zaidi, D. Gibbs, et al. 2001. A two-year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn. Microbiol. Infect. Dis. 4:27-33.
9. Llop, C., J. Sala, M. D. Riba, and J. Guarro. 1999. Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading. Mycopathologia 148:25-31.
10. Manavathu, E. K., U. Nune, K. Kanuri, P. H. Chandrasekar, and O. C. Abraham. 2000. Effect of test medium on in vitro susceptibility testing results for Aspergillus fumigatus. Rev. Iberoam. Micol. 17:107-110.
11. Matar, M. J., L. Ostrosky-Zeichner, V. L. Paetznick, J. R. Rodriguez, E. Chen, and J. H. Rex. 2003. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob. Agents Chemother. 47:1647-1651.
12. Meletiadis, J., J. F. G. M. Meis, J. W. Mouton, and P. E. Verweij. 2001. Analysis of growth characteristics of filamentous fungi in different nutrient media. J. Clin. Microbiol. 39:478-484.
13. Mock, M., M. Monod, F. Baudraz-Rosselet, and R. G. Panizzon. 1998. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo. Dermatology 197:361-367.
14. Müller, F.-M. C., O. Kurzai, J. Hacker, M. Frosch, and F. Mühlschlegel. 2001. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis. J. Antimicrob. Chemother. 48:713-715.
15. National Committee for Clinical Laboratory Standards. 2004. Method for antifungal disk diffusion susceptibility testing of yeasts. Approved guideline M44-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. Odds, F., J. Ausma, F. Van Gerven, F. Woestenborghs, L. Meerpoel, J. Heeres, H. Vanden Bossche, and M. Borgers. 2004. In vitro and in vivo activities of the novel azole antifungal agent R126638. Antimicrob. Agents Chemother. 48:388-391.
17. Pfaller, M. A., S. A. Messer, A. Karlsson, and A. Bolmström. 1998. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J. Clin. Microbiol. 36:2586-2589.
18. Tatsumi, Y., M. Yokoo, H. Senda, and K. Kakehi. 2002. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine. Antimicrob. Agents Chemother. 46:3797-3801.
19. Tortorano, A. M., E. Dannaoui, M. Cogliati, M. A. Piens, A. L. Rigoni, R. Grillot, M. A. Viviani, and E. Network. 2000. Evaluation of different in vitro procedures for testing amphotericin B and itraconazole susceptibility of Aspergillus fumigatus. J. Mycol. Med. 10:123-127.
20. Vandenbossche, I., M. Vaneechoutte, M. Vandevenne, T. De Baere, and G. Verschraegen. 2002. Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory. J. Clin. Microbiol. 40:918-921.
21. Venugopal, P. V., and T. V. Venugopal. 1994. Disk diffusion susceptibility testing of dermatophytes with allylamines. Int. J. Dermatol. 33:730-732.